US 10994014
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
granted A61KA61K47/46A61K47/6849
Quick answer
US patent 10994014 (Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EnGeneIC Molecular Delivery Pty Ltd
- Grant date
- Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K47/46, A61K47/6849, A61K51/1203, A61K9/5068